Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories international Markets Share of Consolidated Net Sales (%) (%)
Form 10-K MD&A Overview
Latest, FY2025
61.0%
Period ended Dec 31, 2025
Change on a year earlier
0.0 pts
61.0% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | International Markets Share of Consolidated Net Sales (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61.0% | 0.0 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | 61.0% | 0.0 pts | SEC Filing (0001628280-25-007110) ↗ |
| FY2023 | Dec 31, 2023 | 61.0% | +3.0 pts | SEC Filing (0001628280-24-005348) ↗ |
| FY2022 | Dec 31, 2022 | 58.0% | – | SEC Filing (0001628280-23-004026) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories International Markets Share of Consolidated Net Sales (%) (%), annual FY2022–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/tot-intl-share
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.